K Kitamura|F Takaku - JoVE Visualize

Showing results (1-10 of 1,856) with videos related to

Pageof 186

Sort By:

American Journal of Clinical Oncology|January 1, 1990

Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderlyK Kitamura, F Takaku

Chest|November 1, 1990

Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosisN Keicho, K Kitamura, F Takaku, et al.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 1, 1993

[Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)]K Kitamura, S Asano, H Mizoguchi, et al.

Immunological Investigations|June 1, 1993

Irreversible suppression of CD8 expression in CD4-CD8+ thymocytes upon in vitro stimulationS Sawada, G Suzuki, K Kitamura, et al.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1995

[Clinical study of ciclosporin in patients with aplastic anemia and pure red-cell aplasia]K Kitamura, A Urabe, T Nomura, et al.

Cellular Immunology|February 1, 1991

Effects of an immunosuppressant, FK506, on interleukin 1 alpha production by human macrophages and a macrophage-like cell line, U937N Keicho, S Sawada, K Kitamura, et al.

Experimental Hematology|November 1, 1983

Enhancement of human T lymphocyte colony formation by 12-O-tetradecanoylphorbol-13-acetate (TPA)K Kitamura, A Urabe, K Ozawa, et al.

Japanese Journal of Cancer Research : Gann|February 1, 1992

Anti-tumor effects of interleukin-4 and interleukin-5 against mouse B cell lymphoma and possible mechanisms of their actionH K Wu, H Hirai, K Inamori, et al.

Blood|June 15, 1993

CD4dull+ hematopoietic progenitor cells in murine bone marrowM Onishi, K Nagayoshi, K Kitamura, et al.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1995

[Therapeutic evaluation of combination therapy using human native immunoglobulin preparation for i.v. administration, with antibiotics and G-CSF in severe infections in the field of internal medicine]K Kitamura, H Mizoguchi, K Hirashima, et al.

Pageof 186

Showing results (1-10 of 1,856) with videos related to

Sort By:

Pageof 186

American Journal of Clinical Oncology|January 1, 1990

Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderlyK Kitamura, F Takaku

Chest|November 1, 1990

Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosisN Keicho, K Kitamura, F Takaku, et al.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 1, 1993

[Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)]K Kitamura, S Asano, H Mizoguchi, et al.

Immunological Investigations|June 1, 1993

Irreversible suppression of CD8 expression in CD4-CD8+ thymocytes upon in vitro stimulationS Sawada, G Suzuki, K Kitamura, et al.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1995

[Clinical study of ciclosporin in patients with aplastic anemia and pure red-cell aplasia]K Kitamura, A Urabe, T Nomura, et al.

Cellular Immunology|February 1, 1991

Effects of an immunosuppressant, FK506, on interleukin 1 alpha production by human macrophages and a macrophage-like cell line, U937N Keicho, S Sawada, K Kitamura, et al.

Experimental Hematology|November 1, 1983

Enhancement of human T lymphocyte colony formation by 12-O-tetradecanoylphorbol-13-acetate (TPA)K Kitamura, A Urabe, K Ozawa, et al.

Japanese Journal of Cancer Research : Gann|February 1, 1992

Anti-tumor effects of interleukin-4 and interleukin-5 against mouse B cell lymphoma and possible mechanisms of their actionH K Wu, H Hirai, K Inamori, et al.

Blood|June 15, 1993

CD4dull+ hematopoietic progenitor cells in murine bone marrowM Onishi, K Nagayoshi, K Kitamura, et al.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1995

[Therapeutic evaluation of combination therapy using human native immunoglobulin preparation for i.v. administration, with antibiotics and G-CSF in severe infections in the field of internal medicine]K Kitamura, H Mizoguchi, K Hirashima, et al.

Pageof 186